During the past decade, Seattle Urology Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Seattle Urology Research Center" are "Nocturia" (3 trials), "Prostate Cancer" (1 trials), "Urinary Frequency" (1 trials) and "Urinary Urgency" (1 trials). Many other conditions were trialed in "Seattle Urology Research Center" in a lesser frequency.

Most popular intervention types in "Seattle Urology Research Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (1 trials), "Desmopressin Melt" (1 trials), "Leuprolide" (1 trials), "Placebo" (1 trials) and "Solifenacin PO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Urology Research Center" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Seattle Urology Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Seattle Urology Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Urology Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".